Italia markets open in 44 minutes

Cronos Group Inc. (CRON)

NasdaqGM - NasdaqGM Prezzo in tempo reale. Valuta in USD.
Aggiungi a portafoglio
5,95+0,15 (+2,59%)
Alla chiusura: 4:00PM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente5,80
Aperto5,78
Denaro0,00 x 1400
Lettera0,00 x 4000
Min-Max giorno5,77 - 6,05
Intervallo di 52 settimane5,17 - 15,83
Volume3.423.350
Media Volume1.774.400
Capitalizzazione2,213B
Beta (5 anni mensile)1,54
Rapporto PE (ttm)N/D
EPS (ttm)-0,41
Prossima data utili03 nov 2021 - 08 nov 2021
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1A6,43
  • GlobeNewswire

    Cronos Group Launches its First Cultured Cannabinoid Product, SPINACH FEELZ™ Chill Bliss 2:1 THC|CBG Gummy

    SPINACH FEELZ™ Chill Bliss 2:1 THC|CBG Gummy Cronos Group unveils its new CBG product, the SPINACH FEELZ™ Chill Bliss 2:1 THC|CBG gummy, made using fermentation and proprietary methods to produce CBG without using the cannabis plant. Cronos Group unveils its new CBG product, the SPINACH FEELZ™ Chill Bliss 2:1 THC|CBG gummy, made using fermentation and proprietary methods to produce CBG without using the cannabis plantThe SPINACH FEELZ™ platform’s latest product innovation, the Chill Bliss gummy,

  • GlobeNewswire

    Cronos Group and Ginkgo Bioworks Announce Achievement of Equity Milestone in Partnership to Produce Cultured Cannabinoids

    By achieving commercial scale production of CBG, the companies are on track to enable access to rare cannabis moleculesTORONTO and BOSTON, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Cronos Group, Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group"), an innovative global cannabinoid company, and Ginkgo Bioworks (“Ginkgo”), which is building the leading horizontal platform for cell programming, today announced the achievement of the first target productivity milestone in their partnership to produce eight cult